
Sue Siegel: Innovation, AI, and the Future of Life Sciences
(00:00) Introduction and about the inaugural Boardroom Governance Summit (03:03) Sue Siegel’s Background: from molecular biology and operating roles to venture capital, GE Ventures, Chief Innovation Officer of GE, and board service (04:14) Innovation as a System: why breakthrough technology alone is not enough, and why boards need to understand the systems required to move innovation from invention to value creation (06:00) When Success Stifles Innovation: why successful core businesses can become one of the biggest obstacles to new ideas, and how boards can help companies challenge what already works (07:40) AI’s Impact on Life Sciences: combining imaging, clinical data, genomics, and other information to generate new insights, predictions, and digital twins (09:33) AI and the Future of Personal Health: how tools like ChatGPT and Claude are changing how patients prepare for medical visits and how AI may reshape disease management (11:33) Precision Medicine: how AI and genomic data are helping identify more personalized cancer therapies and monitor disease progression (13:12) Regulating AI Across the Product Life Cycle: how continuously improving models create new questions about approval, liability, and board oversight in healthcare (16:27) Biotech Funding and the IPO Drought: why capital has become harder to raise in life sciences and how regulation and reimbursement add friction for investors (18:37) Navigating Shareholder Activism: Sue’s experience at Illumina with Carl
Publisher
Boardroom Governance with Evan Epstein
Link
boardroom-governance.simplecast.com/episodes/sue-siegel-summit-2026-wJDKALVQ
Published
October 23, 2026
Duration
29 min
Format
Podcast
Category
Issues · Business
Source
RSS feed
Host
Evan Epstein
Boardroom Governance with Evan Epstein
@boardroomgovernancewithevane
#suesiegel #innovation #sciences #management #courses
